Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/Sanofi-CHMP-recommends-approval-of-Dupixent-for-children-aged-6-to-11-years-with-severe-atopic-d-31567118/?utm_source=whatsapp&utm_medium=social&utm_campaign=share